Hark Kyun Kim
Papers
1
Total Citations
11
H-Index
1
About
Dr. Hark Kyun Kim is a distinguished cancer researcher whose work has significantly advanced the proteomic understanding of lung cancer, particularly through the application of mass spectrometry to clinical biopsy specimens. His key research areas include cancer proteomics, biomarker discovery, and the molecular characterization of small cell lung cancer (SCLC). Dr. Kim’s major contribution lies in pioneering the use of matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) on bronchoscopic biopsy samples—a challenging and minimally invasive tissue source. In his highly cited 2011 study, he demonstrated that a proteomic signature could be obtained from these small samples, revealing decreased calcyclin expression in SCLC. This work, with over 11 citations, established a critical proof-of-concept for applying proteomics to early diagnostic specimens rather than relying solely on surgical resections. By bridging the gap between advanced analytical chemistry and clinical oncology, Dr. Kim has opened new avenues for earlier lung cancer diagnosis and personalized treatment strategies, making his research invaluable for students and clinicians seeking to understand the molecular underpinnings of aggressive thoracic malignancies.
Research Focus
Key Achievements
Top Papers
- 1